| Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. | |
| | |
MedLine Citation:
|
PMID: 17493574 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To present long-term outcomes of Ahmed glaucoma valve implantation for uveitic glaucoma. DESIGN: Interventional case series. METHODS: Retrospective chart review of 60 patients (60 eyes) with uveitic glaucoma who underwent Ahmed valve implantation over a four-year period at a tertiary uveitis referral center. Success definition 1 included patients with an intraocular pressure (IOP) between 5 and 21 mm Hg, reduced by 25% from that before implantation. Success definition 2 (qualified success) excluded those patients in whom serious complications occurred. RESULTS: Mean follow-up time was 30 months (range, six to 87 months; four-year results relate to a cohort of 15 patients). Success rates were 77% and 50% and qualified success rates were 57% and 39% at one and four years, respectively. At four years, 74% of the patients required glaucoma medication to maintain IOP control. The overall complication rate was 12%/person-years. The rate of visual acuity loss was 4%/person-years; that was most commonly attributed to corneal complications that were more likely to occur in patients with preoperative corneal disease (P = .01, Fisher exact test). CONCLUSIONS: Ahmed glaucoma valve implantation is a safe yet moderately successful procedure for uveitic glaucoma. Long-term success rates are enhanced with the use of glaucoma medications, and corneal complications are the most common of all potential serious complications. |
| | |
Authors:
|
Thekla G Papadaki; Ioannis P Zacharopoulos; Louis R Pasquale; William B Christen; Peter A Netland; C Stephen Foster |
Related Documents
:
|
3895104 - Late onset endophthalmitis associated with filtering blebs. 17293784 - Management of glaucoma in patients with nanophthalmos. 19384014 - P53 expression in pterygium in two climatic regions in turkey. 11566524 - Deep sclerectomy with collagen implant in patients with glaucoma and high myopia. 12368724 - Technical considerations for late removal of aortic endografts. 16982984 - The evolution of midface rejuvenation: combining the midface-lift and fat transfer. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-05-09 |
Journal Detail:
|
Title: American journal of ophthalmology Volume: 144 ISSN: 0002-9394 ISO Abbreviation: Am. J. Ophthalmol. Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-07-02 Completed Date: 2007-07-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370500 Medline TA: Am J Ophthalmol Country: United States |
Other Details:
|
Languages: eng Pagination: 62-69 Citation Subset: AIM; IM |
Affiliation:
|
Massachusetts Eye Research and Surgery Institute, Ocular Immunology and Uveitis Foundation, Harvard Medical School Boston, Massachusetts, USA. theklapap@med.uoc.gr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Child Female Follow-Up Studies Glaucoma / physiopathology, surgery* Glaucoma Drainage Implants* Humans Intraocular Pressure / physiology Male Middle Aged Postoperative Complications Prosthesis Implantation Retrospective Studies Treatment Outcome Uveitis / physiopathology, surgery* Visual Acuity / physiology |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Macular schisis and detachment associated with presumed acquired enlarged optic nerve head cups.
Next Document: A high-throughput assay for the adenylation reaction of bacterial DNA ligase.